Clinical trial
A Prospective Observational Study of ENTYVIO Management in Crohn's Disease in Canada: Real-World Experience and Patient-Reported Outcomes
NCT04349449 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study of ENTYVIO Management in Crohn's Disease in Canada: Real-World Experience and Patient-Reported Outcomes
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- September 30, 2020
- Completion date
- November 30, 2022
- Enrollment
- 0 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.